It has been shown that TRAIL-induced apoptosis can be enhanced by chemotherapy in several in vitro and xenograft models of cancer, an effect reported to be mediated through increased DR4 and DR5 expression[36-38]. The gene discussed is TNFRSF10A; the disease is cancer.